| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3263266 | NAT9 | Blood | Tissue | Leukocyte | COVID-19;Control/Healthy | GSE157103 | A3SS | G0/G1 | 17 | - |
PV=1 FDR=1 FC=0.181 |
|
| 3263267 | NAP1L4 | Blood | Tissue | Leukocyte | COVID-19;Control/Healthy | GSE157103 | A3SS | G0/G1 | 11 | - |
PV=0.566 FDR=1 FC=0.005 |
|
| 3263268 | NAP1L4 | Blood | Tissue | Leukocyte | COVID-19;Control/Healthy | GSE157103 | A3SS | G0/G1 | 11 | - |
PV=1 FDR=1 FC=-0.027 |
|
| 3263269 | NAP1L4 | Blood | Tissue | Leukocyte | COVID-19;Control/Healthy | GSE157103 | A3SS | G0/G1 | 11 | - |
PV=1 FDR=1 FC=-0.054 |
